July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Quantitative Ellipsoid Zone Mapping and Integrity Assessment on Optical Coherence Tomography in the VISTA DME Study
Author Affiliations & Notes
  • Leina Moani Lehua Lunasco
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Atsuro Uchida
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Sunil K Srivastava
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Natalia Figueiredo
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Andrea Gibson
    Regeneron, Tarrytown, New York, United States
  • Kim Reed
    Regeneron, Tarrytown, New York, United States
  • Jamie L. Reese
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Justis P Ehlers
    Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Leina Lunasco, None; Atsuro Uchida, None; Sunil Srivastava, Allergan (F), Bausch and Lomb (C), Gilead (F), Leica (P), Regeneron (F), Santen (C); Natalia Figueiredo, None; Andrea Gibson, Regeneron (E); Kim Reed, Regeneron (E); Jamie Reese, None; Justis Ehlers, Aerpio (C), Aerpio (F), Alcon (C), Alcon (F), Alimera (C), Allergan (C), Boerhinger Ingelheim (F), Genentech (C), Leica (C), Leica (P), Novartis (C), Novartis (F), Regeneron (F), Roche (C), Santen (C), Thrombogenics (C), Thrombogenics (F), Zeiss (C)
  • Footnotes
    Support  NIH/NEI K23-EY022947-01A1; RPB Institutional Grant; Regeneron REGE1704JE
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1884. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Leina Moani Lehua Lunasco, Atsuro Uchida, Sunil K Srivastava, Natalia Figueiredo, Andrea Gibson, Kim Reed, Jamie L. Reese, Justis P Ehlers; Quantitative Ellipsoid Zone Mapping and Integrity Assessment on Optical Coherence Tomography in the VISTA DME Study. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1884.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the dynamics of ellipsoid zone (EZ) integrity on spectral domain optical coherence tomography (SD-OCT) in diabetic macular edema (DME) treated with intravitreal aflibercept injection (IAI) in the Phase III VISTA study.

Methods : This was a post hoc subanalysis of the IAI arms of the VISTA study. As per protocol, eyes were initially treated with five monthly 2-mg IAI and then either every 4 weeks (2q4) or 8 weeks (2q8). For this analysis, eyes imaged with the Zeiss Cirrus HD-OCT system were included. The 6 x 6 mm macular cube scan was analyzed for multiple time-points through week 100. Retinal OCT images were evaluated using a novel EZ mapping software platform with manual correction as needed to generate retinal layers for assessment of change in ellipsoid zone (EZ) parameters, including macular EZ-RPE volume and en face EZ integrity maps. Correlation analysis was conducted either with the Pearson correlation test or Spearman’s rank correlation test.

Results : A total of 106 eyes were included. EZ integrity was improved as measured by EZ-RPE volume (p=0.01) and reduction in EZ attenuation (p<0.001) in both the 2q4 and 2q8 groups. Central subfield EZ-RPE volume at week 100 directly correlated with final best corrected visual acuity (BCVA, p<0.01).

Conclusions : IAI resulted in significant improvement in EZ integrity metrics in both 2q4 and 2q8 groups. Central subfield EZ metrics exhibited the highest correlation with final BCVA. Future research is focused on identifying potential imaging biomarkers that may help predict functional and anatomic outcomes.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×